GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (TSXV:IBO) » Definitions » Short Interest

Universal Ibogaine (TSXV:IBO) Short Interest


View and export this data going back to 2017. Start your Free Trial

What is Universal Ibogaine Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Universal Ibogaine's Short Interest

For the Biotechnology subindustry, Universal Ibogaine's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Universal Ibogaine's Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Universal Ibogaine's Short Interest distribution charts can be found below:

* The bar in red indicates where Universal Ibogaine's Short Interest falls into.


Universal Ibogaine (TSXV:IBO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (TSXV:IBO) » Definitions » Short Interest
Comparable Companies
XCNQ:NIRV TSXV:WAVE TSXV:SVS TSXV:VXL TSXV:PSYB XCNQ:CURE XCNQ:CMND TSX:IPCI XCNQ:AGN TSXV:MRVL OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
IBOGF:USA JC4:Germany
Address
400 3rd Avenue South west, Suite 1470, Calgary, AB, CAN, T2P 4H2
Website
https://www.universalibogaine.com
Universal Ibogaine Inc develops a platform of addiction treatment clinics, which use ibogaine as a primary modality for the interruption and ideally cessation of addictions to primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. It runs addiction clinics it has a research partner clinic in Mexico.
Executives
Ian Rabb Senior Officer

Universal Ibogaine (TSXV:IBO) Headlines

No Headlines